Looking for our Business Solutions? Click here:
CloudQuote APIs
Contact Us
Stocks
News
ETFs
Economy
Currencies
Press Releases
Grace Therapeutics, Inc. - Common Stock (GRCE)
Last Price
2.1500
Change
-0.0200 (-0.92%)
NASDAQ
· Last Trade: May 19th, 11:09 PM EDT
Quote
News
Press Releases
Chart
Historical
FAQ
About
Competitors
Thursday's session: top gainers and losers
chartmill.com
Via
Chartmill
· April 23, 2026
Which stocks are moving on Tuesday?
chartmill.com
Via
Chartmill
· April 7, 2026
Gapping stocks in Tuesday's session
chartmill.com
Via
Chartmill
· April 7, 2026
Small-Cap Grace Therapeutics Touts Positive Data From Brain Hemorrhage Study
benzinga.com
Grace Therapeutics' GTx-104 met its Phase 3 trial endpoint, showing clinical benefits over oral nimodipine. US NDA submission is expected in early 2025.
Via
Benzinga
· February 10, 2025
